drugset / Trial / NCT04767113

Continuous Heparin Infusion to Prevent Catheter-related Thrombosis

NCT04767113

RandomizedParallel-groupDouble-blindPrevention

Summary

Catheter-related thrombosis could impair blood flow in the vein, block the central venous catheter, induce catheter-related infection or venous thromboembolism in the deep veins or pulmonary vessels, which furthermore progress into the post-thrombotic syndrome. Researches using echogenic mass as the primary outcome could miss those premature thrombi which might not be seen on traditional ultrasonography but may be detected by Duplex and Doppler ultrasound with vessel compression. Moreover, studies indicated that some thrombus developed after the catheter removal. Removal of the catheter is not the endpoint of thrombus detection. This study is designed to determine the preventive effects of continuous heparin infusion on real-world central venous catheter-related thrombosis in infants after cardiac surgery.

Timeline

Start
2021-03-01
Primary completion
2022-08-31
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 0.5 iu/kg Intravenous
Subject Heparin Other / unclassified 1 iu/kg Intravenous
Subject Heparin Other / unclassified 10 iu/kg Intravenous
Subject Heparin Other / unclassified 15 iu/kg Intravenous